FDA Adverse Event Malfunction Summary report: N

FREESTYLE LIBRE 2 PLUS

MDR report key: 23244778 · Received October 8, 2025

Report

Report Number
2954323-2025-40021
Event Type
Malfunction
Date Received
October 8, 2025
Date of Event
September 28, 2025
Report Date
April 10, 2026
Manufacturer
ABBOTT DIABETES CARE INC
Product Code
QBJ
UDI-DI
00357599871000
PMA / PMN Number
K223435
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

SENSOR (B)(6) HAS BEEN RETURNED AND INVESTIGATED. THE SENSOR PLUG IS FULLY SEATED AND NO ISSUES WERE OBSERVED ON THE SENSOR PATCH. EXTRACTED DATA FROM THE RETURNED SENSOR USING APPROVED SOFTWARE. THE SENSOR WAS FOUND TO BE IN SENSOR STATE 5 (INDICATING NORMAL TERMINATION). SENSOR STATE 5 WITH EVENT LOGS 3 AND 4 ARE AN INDICATION OF NORMAL TERMINATION OF THE SENSOR WITHOUT ANY ERROR. VISUAL INSPECTION HAS BEEN PERFORMED ON THE SENSOR PLUG ASSEMBLY, NO FAILURE MODES WERE OBSERVED. CIG ATTEMPTED TO REPROGRAM THE RETURNED PATCH, HOWEVER AN ERROR OCCURRED DURING REPROGRAMMING. THIS ERROR PREVENTED THE RETURNED PATCH FROM BEING REPROGRAMMED AND THEREFORE, CIG WAS UNABLE TO TEST THIS ISSUE. FURTHER INVESTIGATION WAS CONDUCTED. VISUAL INSPECTION HAS BEEN PERFORMED AND NO ISSUES OBSERVED. THE SENSOR EVENT LOG WAS UNABLE TO BE EXTRACTED AND ALSO UNABLE TO REPROGRAMED THE SENSOR THROUGH THE PATCH PROGRAMMER. BENCH TESTING WAS PERFORMED ON THE RETURNED SENSOR. THE RETURNED SENSOR WAS PLACED ON THE EVM (EVALUATION MODULE) AND WAS VERIFIED TO BE UNABLE TO SCAN WITH THE OBSERVED ERROR MESSAGE DEVICE NOT COMPATIBLE. DUE TO THE INABILITY OF THE SENSOR TO SCAN OR BE REPROGRAMMED, FURTHER FUNCTIONALITY TESTING WAS UNABLE TO BE PERFORMED. THE ISSUE OF THE SENSOR EXHIBITING LOW GLUCOSE READINGS WAS UNABLE TO TEST DUE TO THE RETURNED SENSOR BEING UNABLE TO SCAN, WHICH WAS AN INDICATION OF DATA CORRUPTION TO THE SENSOR. SECTION H6 (INVESTIGATION FINDINGS) CODE C20 (NO FINDINGS AVAILABLE) AND D15 CAUSE NOT ESTABLISHED WAS SELECTED, AS ADC WAS UNABLE TO PERFORM FURTHER TESTING ON THE RETURNED DEVICE. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT DIABETES CARE HAS BEEN SUBMITTED.

Additional Manufacturer Narrative · 0

REPEATED ATTEMPTS BY ADC TO RETRIEVE THE PRODUCT WERE UNSUCCESSFUL AND/OR THE CUSTOMER DISCARDED THE PRODUCT. THE MOST PROBABLE ROOT CAUSES ASSOCIATED WITH THIS FAILURE MODE ARE DISCONNECTED, FAULTY OR DAMAGED COMPONENTS, SOFTWARE/DATA CORRUPTION, OR MISUSE. HOWEVER, MITIGATIONS ARE IN PLACE TO REDUCE AND PREVENT SUCH ISSUES. ALL VITAL MANUFACTURING STEPS ARE VALIDATED, MONITORED, AND VERIFIED DURING MANUFACTURING TO ENSURE THE SYSTEM IS IN CONFORMANCE WITH THE VERIFIED DESIGN. ALL VITAL FUNCTIONS ARE MONITORED BY THE SYSTEM AND, WHEN NECESSARY, FUNCTION IS SUSPENDED TO SAFEGUARD AGAINST INACCURATE RESULTS. LABELING IS PROVIDED TO INSTRUCT THE USER ON THE INTENDED USE OF ALL VITAL PARTS OF THE SYSTEM TO MINIMIZE MISUSE. ALL COMPLAINTS AND COMPLAINT TRENDS ARE INVESTIGATED TO DETERMINE IF THERE IS A PRODUCT DEFECT/ DEFICIENCY. IF A PRODUCT DEFECT/ DEFICIENCY IS IDENTIFIED, A RISK EVALUATION IS COMPLETED AND COMPARED TO THE RISK MANAGEMENT REPORT, TO ENSURE THE RISK PROFILE HAS NOT CHANGED. ADDITIONALLY, AS A PART OF ABBOTT¿S POST-MARKET SURVEILLANCE PROCESS, ALL RISK EVALUATIONS WITH ASSOCIATED COMPLAINT DATA ARE REVIEWED ANNUALLY TO DETERMINE IF THE RISK PROFILES HAVE CHANGED AS COMPARED TO THE PRODUCT RISK MANAGEMENT REPORTS. THESE MONITORING PROCESSES ENSURE THAT ALL PRODUCT RISK PROFILES REMAIN ACCEPTABLE AND HAVE A POSITIVE BENEFIT/ RISK RATIO. AT THIS TIME, THE PRODUCT HAS NOT YET BEEN RETURNED FOR THIS COMPLAINT. AN EXTENDED INVESTIGATION HAS BEEN PERFORMED FOR THE REPORTED COMPLAINT AND THERE WAS NO INDICATION THAT THE PRODUCT DID NOT MEET SPECIFICATION. DHRS (DEVICE HISTORY REVIEW) FOR THE LIBRE SENSOR AND SENSOR KIT WAS REVIEWED AND THE DHRS SHOWED THE LIBRE SENSOR AND SENSOR KIT MEET SPECIFICATIONS PRIOR TO RELEASE TO DISTRIBUTION. IF THE PRODUCT IS RETURNED, A PHYSICAL INVESTIGATION WILL BE PERFORMED AND A FOLLOW-UP REPORT WILL BE SUBMITTED. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT DIABETES CARE HAS BEEN SUBMITTED.

Description of Event or Problem · 0

A CUSTOMER REPORTED RECEIVING ERRONEOUS GLUCOSE RESULTS FROM AN ABBOTT DIABETES CARE DEVICE. THE CUSTOMER RECEIVED SENSOR SCAN RESULTS OF 77 MG/DL COMPARED TO READINGS OF 200 MG/DL RESPECTIVELY OBTAINED ON A METER AND THE RESULTS, WHEN PLOTTED ON A PARKES ERROR GRID, FALL INTO THE C ZONE, SHOWING THE DIFFERENCE IN VALUES TO BE CLINICALLY SIGNIFICANT. THE LENGTH OF SENSOR WEAR WAS 12 DAYS. THERE WAS NO REPORT OF DEATH, SERIOUS INJURY, OR MISTREATMENT ASSOCIATED WITH THIS EVENT.

Description of Event or Problem · 0

A CUSTOMER REPORTED RECEIVING ERRONEOUS GLUCOSE RESULTS FROM AN ABBOTT DIABETES CARE DEVICE. THE CUSTOMER RECEIVED SENSOR SCAN RESULTS OF 77 MG/DL COMPARED TO READINGS OF 200 MG/DL RESPECTIVELY OBTAINED ON A METER AND THE RESULTS, WHEN PLOTTED ON A PARKES ERROR GRID, FALL INTO THE C ZONE, SHOWING THE DIFFERENCE IN VALUES TO BE CLINICALLY SIGNIFICANT. THE LENGTH OF SENSOR WEAR WAS 12 DAYS. THERE WAS NO REPORT OF DEATH, SERIOUS INJURY, OR MISTREATMENT ASSOCIATED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2513225 FREESTYLE LIBRE 2 PLUS FLASH GLUCOSE MONITORING SYSTEM QBJ ABBOTT DIABETES CARE INC 78747-01 00357599871000

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown